Generics manufacturer, Teva has announced the appointment of Dr Phillip Frost to the role of chairman of the Board of Directors
The US FDA has approved Allergan's Botox (onabotulinumtoxinA) for the treatment of elbow, wrist and finger stiffness in adults
Abbott is to acquire Facet Biotech in a deal valued at approximately $722m, strengthening Abbott's capabilities in biologics in immunology and oncology
US firm agrees to employ ethics 'watchdogs' as part of lawsuit settlements
Sixty per cent of English hospitals are providing misleading performance assessments according to a BBC documentary
Treatments aimed at preventing the loss of dopaminergic function are entering the pipeline
The marketing mix is a powerful tool that works well not just in consumer markets but also in pharma
Recently retired CEO of Roche Pharmaceuticals, Bill Burns, remains up-beat about the future of the industry
Robust links in cold chain supply are vital to ensure both public health and company profits
Pharma companies need to nurture in-house skills and sculpt organisational structures to better meet the needs of their various stakeholders
